126 related articles for article (PubMed ID: 11507290)
1. Tc-99m mercaptoacetyltriglycine clearance: comparison of camera-assisted methods.
Bocher M; Shrem Y; Tappiser A; Klein M; Schechter D; Taylor A; Chisin R
Clin Nucl Med; 2001 Sep; 26(9):745-50. PubMed ID: 11507290
[TBL] [Abstract][Full Text] [Related]
2. Multicenter trial validation of a camera-based method to measure Tc-99m mercaptoacetyltriglycine, or Tc-99m MAG3, clearance.
Taylor A; Manatunga A; Morton K; Reese L; Prato FS; Greenberg E; Folks R; Kemp BJ; Jones ME; Corrigan PE; Galt J; Eshima L
Radiology; 1997 Jul; 204(1):47-54. PubMed ID: 9205222
[TBL] [Abstract][Full Text] [Related]
3. Overall accuracy of technetium-99m-MAG3 clearance measurements obtained with a gamma camera heart curve.
Tondeur M; Kinthaert J; Piepsz A; Ham HR
J Nucl Med; 1996 Aug; 37(8):1281-4. PubMed ID: 8708756
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-mercaptoacetyltriglycine camera-based measurement of renal clearance: should the result be normalized for body surface area?
Klingensmith WC
J Nucl Med Technol; 2013 Dec; 41(4):279-82. PubMed ID: 24167023
[TBL] [Abstract][Full Text] [Related]
5. Deadtime correction in measurement of fractional renal accumulation of 99Tcm-MAG3.
Inoue Y; Ohtake T; Yokoyama I; Yoshikawa K; Ohtomo K
Nucl Med Commun; 1999 Mar; 20(3):267-72. PubMed ID: 10093077
[TBL] [Abstract][Full Text] [Related]
6. Estimation of Tc-99m MAG3 clearance using camera-based methods without blood sampling.
Inoue Y; Ohtomo K
Clin Nucl Med; 2011 Nov; 36(11):1012-6. PubMed ID: 21975390
[TBL] [Abstract][Full Text] [Related]
7. Reproducibility of technetium-99m mercaptoacetyltriglycine clearance in patients with impaired renal function.
Erdil TY; Dede F; Tuglular S; Sen F; Ones T; Farsakoglu Z; Inanir S; Ozener C; Akoglu E; Turoglu T
Nucl Med Commun; 2006 Feb; 27(2):191-6. PubMed ID: 16404234
[TBL] [Abstract][Full Text] [Related]
8. Determination of extrarenal plasma clearance and hepatic uptake of technetium-99m-mercaptoacetyltriglycine in cats.
Drost WT; McLoughlin MA; Mattoon JS; Lerche P; Samii VF; DiBartola SP; Chew DJ; Barthez PY
Am J Vet Res; 2003 Sep; 64(9):1076-80. PubMed ID: 13677382
[TBL] [Abstract][Full Text] [Related]
9. Optimization of the uptake method for estimating renal clearance of 99mTc mercaptoacetyltriglycine.
Zhao C; Shuke N; Okizaki A; Yamamoto W; Usui K; Kikuchi K; Kaneko S; Yachiku S; Sasajima T; Aburano T
Nucl Med Commun; 2004 Feb; 25(2):159-66. PubMed ID: 15154706
[TBL] [Abstract][Full Text] [Related]
10. Monitoring renal function: a prospective study comparing camera-based technetium-99m mercaptoacetyltriglycine clearance and creatinine clearance.
Halkar R; Taylor A; Manatunga A; Issa MM; Myrick SE; Grant S; Shenvi NV
Urology; 2007 Mar; 69(3):426-30. PubMed ID: 17382136
[TBL] [Abstract][Full Text] [Related]
11. Comparison of camera-based 99mTc-MAG3 and 24-hour creatinine clearances for evaluation of kidney function.
Esteves FP; Halkar RK; Issa MM; Grant S; Taylor A
AJR Am J Roentgenol; 2006 Sep; 187(3):W316-9. PubMed ID: 16928911
[TBL] [Abstract][Full Text] [Related]
12. [Proposal on new formulas for renal depth in the technetium-99m-mercaptoacetyltriglycine (MAG3) scintigraphy].
Uchiyama K; Kuniyasu Y; Niio Y; Hasebe S; Yamada M; Shinohara H; Matsuoka S; Shima H; Obuchi M; Takizawa K; Honda M; Kawabe R; Kuwayama J; Iwasaki S; Ideura T
Kaku Igaku; 1997 Mar; 34(3):159-66. PubMed ID: 9136524
[TBL] [Abstract][Full Text] [Related]
13. Estimation of 99mTc-MAG3 clearance by single-sample methods and camera-based methods.
Inoue Y; Yoshikawa K; Yokoyama I; Ohtomo K
Ann Nucl Med; 2000 Oct; 14(5):329-32. PubMed ID: 11108160
[TBL] [Abstract][Full Text] [Related]
14. A comparison of single plasma sample methods to estimate renal clearance using 99mTc-ethylenedicysteine and 99mTc-mercaptoacetyltriglycine.
Sohaib M; Rafique A; Saeed S; Afshan A
Clin Physiol Funct Imaging; 2013 Sep; 33(5):353-8. PubMed ID: 23701132
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-MAEC complexes: new renal radiopharmaceuticals combining characteristics of (99m)Tc-MAG3 and (99m)Tc-EC.
Taylor AT; Lipowska M; Hansen L; Malveaux E; Marzilli LG
J Nucl Med; 2004 May; 45(5):885-91. PubMed ID: 15136640
[TBL] [Abstract][Full Text] [Related]
16. 99mTc-MAG3 renography: normal values for MAG3 clearance and curve parameters, excretory parameters, and residual urine volume.
Esteves FP; Taylor A; Manatunga A; Folks RD; Krishnan M; Garcia EV
AJR Am J Roentgenol; 2006 Dec; 187(6):W610-7. PubMed ID: 17114514
[TBL] [Abstract][Full Text] [Related]
17. Estimation of technetium-99m-MAG3 renal clearance in children: two gamma camera techniques compared with multiple plasma samples.
Gordon I; Anderson PJ; Orton M; Evans K
J Nucl Med; 1991 Sep; 32(9):1704-8. PubMed ID: 1831838
[TBL] [Abstract][Full Text] [Related]
18. Measuring technetium-99m-MAG3 clearance with an improved camera-based method.
Taylor A; Corrigan PL; Galt J; Garcia EV; Folks R; Jones M; Manatunga A; Eshima D
J Nucl Med; 1995 Sep; 36(9):1689-95. PubMed ID: 7658232
[TBL] [Abstract][Full Text] [Related]
19. Effects of radiofrequency ablation on individual renal function: assessment by technetium-99m mercaptoacetyltriglycine renal scintigraphy.
Mukai T; Sato S; Iguchi T; Mimura H; Yasui K; Gobara H; Saika T; Nasu Y; Kumon H; Kanazawa S
Acta Med Okayama; 2006 Apr; 60(2):85-91. PubMed ID: 16680184
[TBL] [Abstract][Full Text] [Related]
20. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
